APA (7th ed.) Citation

Perrin, S., Ladha, S., Maragakis, N., Rivner, M. H., Katz, J., Genge, A., . . . Paganoni, S. (2024). Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial. PLoS Medicine, 21(10), 1. https://doi.org/10.1371/journal.pmed.1004469

Chicago Style (17th ed.) Citation

Perrin, Steven, et al. "Safety and Tolerability of Tegoprubart in Patients with Amyotrophic Lateral Sclerosis: A Phase 2A Clinical Trial." PLoS Medicine 21, no. 10 (2024): 1. https://doi.org/10.1371/journal.pmed.1004469.

MLA (9th ed.) Citation

Perrin, Steven, et al. "Safety and Tolerability of Tegoprubart in Patients with Amyotrophic Lateral Sclerosis: A Phase 2A Clinical Trial." PLoS Medicine, vol. 21, no. 10, 2024, p. 1, https://doi.org/10.1371/journal.pmed.1004469.